Login to Your Account

Shanghai plots to become biopharma R&D nexus of China

By Cornelia Zou
Staff Writer

Wednesday, February 19, 2014

HONG KONG – Shanghai, the economic hub of China, wants to recreate itself into the biopharmaceutical development center of China, aiming to generate ¥350 billion (US$57.7 billion) in economic aggregate by the end of 2017.

To continue reading subscribe now to BioWorld Asia (formerly International)

Learn More about BioWorld Asia (formerly International)

Already a subscriber? Sign In or Buy now to activate your subscription